Noncirrhotic Portal Hypertension Secondary to Nodular Regenerative Hyperplasia Postrenal Transplant.

Piao, Cindy; Koul, Abhinav; Gui, Dorina; Chen, Ling-Xin; Sarkar, Souvik

Piao, Cindy; Koul, Abhinav; Gui, Dorina; Chen, Ling-Xin; Sarkar, Souvik.

Afiliación

Piao C; Department of Internal Medicine, Sacramento, CA.
Koul A; Department of Internal Medicine, Sacramento, CA.
Gui D; Division of Gastroenterology and Hepatology, Sacramento, CA.
Chen LX; Department of Pathology, Sacramento, CA.
Sarkar S; Transplant Nephrology, University of California Davis, Sacramento, CA.

ACG Case Rep J ; 6(12): e00257, 2019 Dec.

Article en En | MEDLINE | ID: mdl-32042840

RESUMEN

Noncirrhotic portal hypertension (NCPH) is a well-known clinical entity, but often underdiagnosed. One of the common causes of NCPH is nodular regenerative hyperplasia (NRH) that presents as nodularity with features of portal hypertension and thus often diagnosed as cirrhosis. Although NRH has no histologic fibrosis, the liver synthetic function remains intact; thus, clinical diagnosis is essential because management may differ from cirrhosis. We were asked to consult in this series of 4 patients who had new-onset ascites after kidney transplantation and were diagnosed with NCPH from NRH.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACG Case Rep J Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google